AbbVie Inc. (ABBV) vs Dover Corporation (DOV)
A side-by-side comparison of AbbVie Inc. and Dover Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; DOV is classified in Industrials. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$262.12HealthcareDelayed quote: Sep 14, 2026, 3:55 PM EDT
DOV
Dover Corporation
$189.00IndustrialsDelayed quote: Sep 14, 2026, 3:55 PM EDT
Total return — ABBV vs DOV
growth of $100 · dividends reinvested · last 10yABBV +512.1% (+19.9%/yr)DOV +278.5% (+14.2%/yr)ABBV compounded faster over this window
ABBV DOV
ABBV vs DOV: by the numbers
- •ABBV is the larger company ($463.11B vs $25.45B market cap).
- •DOV trades at the lower trailing earnings multiple (22.83 vs 73.85 P/E), one valuation lens rather than an overall verdict.
- •DOV converts more revenue to profit (13.48% vs 9.81% net margin).
- •ABBV grew revenue faster over the past five years (3.69% vs 2.54% CAGR).
- •ABBV pays the higher dividend yield (2.66% vs 1.10%).
Metrics side by side
Valuation
| Metric | ABBV | DOV |
|---|---|---|
| P/E ratio | 73.85 | 22.83 |
| Forward P/E | 18.66 | 17.67 |
| P/S ratio | 7.19 | 3.02 |
| P/B ratio | N/A | 3.30 |
| EV / EBITDA | 19.68 | 14.88 |
| FCF yield | 3.92% | 4.61% |
Profitability
| Metric | ABBV | DOV |
|---|---|---|
| Gross margin | 71.48% | 39.58% |
| Operating margin | 29.32% | 16.87% |
| Net margin | 9.81% | 13.48% |
| ROE | N/A | 14.73% |
| ROIC | 13.46% | 9.56% |
Dividends
| Metric | ABBV | DOV |
|---|---|---|
| Dividend yield | 2.66% | 1.10% |
| Payout ratio | 192.43% | 25.18% |
Growth (annualized)
| Metric | ABBV | DOV |
|---|---|---|
| Revenue CAGR (5Y) | 3.69% | 2.54% |
| EPS CAGR (5Y) | -2.79% | 10.95% |
| FCF CAGR (5Y) | 0.11% | 2.55% |
| Total return CAGR (5Y) | 23.70% | 2.98% |
Frequently asked
- Which has the lower trailing P/E, ABBV or DOV?
- DOV has the lower trailing P/E: ABBV trades at 73.85 and DOV at 22.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or DOV?
- Over the past five years, ABBV grew revenue faster — ABBV at a 3.69% CAGR versus DOV at 2.54%.
- Does ABBV or DOV pay a bigger dividend?
- ABBV yields 2.66% and DOV yields 1.10% based on trailing dividends and the latest price.
- Is ABBV or DOV more profitable?
- DOV runs the higher net margin — ABBV at 9.81% versus DOV at 13.48%.
- How have ABBV and DOV total returns compared?
- Over the past 10 years, ABBV delivered 19.85% and DOV delivered 14.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioDover P/E ratioAbbVie dividend yieldDover dividend yieldAbbVie ROEDover ROEAbbVie operating marginDover operating marginAbbVie revenue growthDover revenue growthAbbVie free cash flowDover free cash flow
AbbVie & Dover appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.